HOUSE DOCKET, NO. 939        FILED ON: 1/18/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 600

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Daniel Cullinane

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act to reduce prescription drug abuse testing and fraud prevention.

_______________

PETITION OF:

HOUSE DOCKET, NO. 939        FILED ON: 1/18/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 600

The Commonwealth of Massachusetts

_______________

In the One Hundred and Ninetieth General Court
(2017-2018)

_______________

An Act to reduce prescription drug abuse testing and fraud prevention.

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

Chapter 118E of the general laws is hereby amended by adding at the end of SECTIN 77 the following new SECTION:

SECTION 78.  To ensure appropriate and responsible use of drug testing, the office of Medicaid shall implement medical necessity documentation and utilization frequency guidelines, as outlined by the Centers for Medicare and Medicaid Services (CMS).  The office of Mediciad shall require providers to demonstrate utilization and frequency control programs.

Notwithstanding any general or special law to the contrary an independent clinical laboratory that is the out-of-state and accredited by the College of American Pathologists shall be deemed eligible and qualified to participate as a masshealth provider and eligible for payment.